Anemia in Children: A Clinical Sign with Diverse Etiologies

In pediatric practice, anemia should be approached primarily as a hematologic manifestation rather than a standalone diagnosis. It reflects an imbalance in red blood cell (RBC) kinetics decreased production, increased destruction, or blood loss-necessitating targeted evaluation to identify the underlying pathology. Etiologic Classification ۱. Hypoproliferative anemias - Result from reduced erythropoiesis, commonly due to iron deficiency, vitamin B۱۲ or folate deficiency, anemia of chronic disease, hypothyroidism, or bone marrow suppression secondary to infection, chemotherapy, or chronic inflammation. ۲. Hemorrhagic anemias - Acute losses (trauma, gastrointestinal bleeding) or chronic occult losses (Meckel's diverticulum, inflammatory bowel disease, heavy menstrual bleeding). ۳. Hemolytic anemias Congenital (sickle cell disease, thalassemia, hereditary spherocytosis, G۶PD deficiency) or acquired (autoimmune hemolysis, microangiopathic hemolytic anemia, infections, toxins). ۴. Aplastic anemia - Global marrow failure from idiopathic aplasia, viral infections, drugs, or congenital marrow failure syndromes. ۵. Myelophthisic anemia Marrow replacement by malignant infiltration, fibrosis, or storage disorders. Diagnostic Algorithm A CBC with differential and peripheral smear remain initial cornerstones. The mean corpuscular volume (MCV) classifies anemia as microcytic, normocytic, or macrocytic, narrowing the differential. The reticulocyte count stratifies marrow activity: Low reticulocyte index _x۰۰۰۲_۱۲ decreased RBC production. Elevated reticulocyte index _x۰۰۰۲_۱۲ hemolysis or recent blood loss. Morphologic features (target cells, spherocytes, schistocytes, basophilic stippling, hypersegmented neutrophils) provide diagnostic clues. Further work-up includes iron profile, ferritin, vitamin B۱۲ and folate levels, direct antiglobulin test, hemolysis markers (LDH, indirect bilirubin, haptoglobin), and bone marrow aspiration/biopsy when indicated. Therapeutic Approach Management is etiology-specific: Iron supplementation for iron deficiency. Parenteral vitamin B۱۲ or oral folate for megaloblastic anemia. Immunosuppressive regimens or hematopoietic stem cell transplantation for aplastic anemia. Chronic transfusion programs, hydroxyurea, or splenectomy for select hemolytic disorders. Transfusion support is reserved for hemodynamically significant anemia. Prompt recognition, targeted diagnostics, and correction of the primary disorder are essential to prevent developmental, cognitive, and cardiovascular sequelae. Conclusion Anemia in children is a sentinel finding. A systematic, physiology-based classification and disciplined diagnostic pathway enable pediatricians to efficiently identify the cause and initiate definitive treatment, ensuring optimal long-term outcomes.